The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor.
Open accessAbstract
Tissue-type plasminogen activator and urokinase are serine proteases secreted by many cell types that participate in biological processes, such as tissue restructuring, cell migration, and tumor metastasis. Clinically, these proteases are used to dissolve coronary fibrin clots that are the proximal causes of acute myocardial infarction. In vivo, the activity of these enzymes is controlled by plasminogen-activator inhibitors, members of the serpin family of protease inhibitors. This study shows that tissue-type plasminogen activator-inhibitor complexes bind in solution to low density lipoprotein receptor-related protein (LRP), a large heterodimeric ubiquitous membrane receptor. In cultured cells, endocytosis and degradation of these complexes is reduced by polyclonal antibodies directed against LRP and inhibited by a M(r) 39,000 protein that binds to LRP and inhibits its interaction with previously known ligands, including apolipoprotein E and alpha 2-macroglobulin. We propose a role for LRP in the clearance of plasminogen activator-inhibitor complexes that is analogous to its function in the endocytosis of alpha 2-macroglobulin-protease complexes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Kowal, R. C., Herz, J., Weisgraber, K. H., Mahley, R. W., Brown, M. S., & Goldstein, J. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)87014-4 · Cited by 445
Self-citation
Cited by
Serpin Structure, Mechanism, and Function
Gettins, P. G. W. (2002) · Chemical Reviews · doi:10.1021/cr010170+ · Cited by 1,226
Molecular genetics of the LDL receptor gene in familial hypercholesterolemia
Hobbs, H. H., Brown, M. S., & Goldstein, J. L. (1992) · Human Mutation · doi:10.1002/humu.1380010602 · Cited by 921
Senescence-messaging secretome: SMS-ing cellular stress
Kuilman, T., & Peeper, D. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2560 · Cited by 909
CD91: a receptor for heat shock protein gp96
Binder, R. J., Han, D. K., & Srivastava, P. K. (2000) · Nature Immunology · doi:10.1038/77835 · Cited by 671
VAUGHAN, D. E. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01420.x · Cited by 507
Willnow, T. E., Goldstein, J. L., Orth, K., Brown, M. S., & Herz, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35732-6 · Cited by 460
Self-citationLipoprotein receptors in the nervous system
Herz, J., & Bock, H. H. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135342 · Cited by 457
Self-citationAn Extracellular Proteolytic Cascade Promotes Neuronal Degeneration in the Mouse Hippocampus
Tsirka, S. E., Rogove, A. D., Bugge, T. H., Degen, J. L., & Strickland, S. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-02-00543.1997 · Cited by 430
Kounnas, M. Z., Moir, R. D., Rebeck, G. W., Bush, A. I., Argraves, W. S., Tanzi, R. E., Hyman, B. T., & Strickland, D. K. (1995) · Cell · doi:10.1016/0092-8674(95)90320-8 · Cited by 401
THE MAMMALIAN LOW-DENSITY LIPOPROTEIN RECEPTOR FAMILY
Hussain, M. M., Strickland, D. K., & Bakillah, A. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.141 · Cited by 377
Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal Women
Koh, K. K., Mincemoyer, R., Bui, M. N., Csako, G., Pucino, F., Guetta, V., Waclawiw, M., & Cannon, R. O. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361002 · Cited by 373
Bu, G., Williams, S., Strickland, D. K., & Schwartz, A. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7427 · Cited by 314
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
Nykjar, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2610 · Cited by 309
Inhibition of Hepatic Chylomicron Remnant Uptake by Gene Transfer of a Receptor Antagonist
Willnow, T. E., Sheng, Z., Ishibashi, S., & Herz, J. (1994) · Science · doi:10.1126/science.7515194 · Cited by 301
Self-citationBu, G., Geuze, H. J., Strous, G. J., & Schwartz, A. L. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07221.x · Cited by 274
LDL receptor‐related protein: a multiligand receptor for lipoprotein and proteinase catabolism
Strickland, D. K., Kounnas, M. Z., & Argraves, W. S. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7615159 · Cited by 268
Role of Tissue Plasminogen Activator Receptor LRP in Hippocampal Long-Term Potentiation
Zhuo, M., Holtzman, D. M., Li, Y., Osaka, H., DeMaro, J., Jacquin, M., & Bu, G. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00542.2000 · Cited by 258
Rebeck, G. W., Harr, S. D., Hyman, B. T., & Strickland, D. K. (1995) · Annals of Neurology · doi:10.1002/ana.410370212 · Cited by 232
Willnow, T. E., Armstrong, S. A., Hammer, R. E., & Herz, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4537 · Cited by 228
Self-citationBu, G., Maksymovitch, E. A., Nerbonne, J. M., & Schwartz, A. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32340-2 · Cited by 185
Battey, F. D., Gåfvels, M. E., FitzGerald, D. J., Argraves, W. S., Chappell, D. A., Strauss, J. F., & Strickland, D. K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31648-4 · Cited by 150
Sarafanov, A. G., Ananyeva, N. M., Shima, M., & Saenko, E. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008046200 · Cited by 116
Williams, S. E., Inoue, I., Tran, H., Fry, G. L., Pladet, M. W., Iverius, P. H., Lalouel, J. M., Chappell, D. A., & Strickland, D. K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37017-5 · Cited by 103
Evidence for a second alpha 2-macroglobulin receptor.
Misra, U. K., Chu, C. T., Gawdi, G., & Pizzo, S. V. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99909-6 · Cited by 102
The 39-kDa Receptor-associated Protein Modulates Lipoprotein Catabolism by Binding to LDL Receptors
Medh, J. D., Fry, G. L., Bowen, S. L., Pladet, M. W., Strickland, D. K., & Chappell, D. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.536 · Cited by 94
Wheal, H. V., Chen, Y., Mitchell, J., Schachner, M., Maerz, W., Wieland, H., van Rossum, D., & Kirsch, J. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00026-4 · Cited by 93
Hiesberger, T., Hüttler, S., Rohlmann, A., Schneider, W., Sandhoff, K., & Herz, J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4617 · Cited by 74
Self-citationMärz, W., Beckmann, A., Scharnagl, H., Siekmeier, R., Mondorf, U., Held, I., Schneider, W., Preissner, K. T., Curtiss, L. K., Groß, W., et al. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81087-g · Cited by 67
Lopes, M. B. S., Bogaev, C. A., Gonias, S. L., & VandenBerg, S. R. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80288-2 · Cited by 64
Iadonato, S. P., Bu, G., Maksymovitch, E. A., & Schwartz, A. L. (1993) · Biochemical Journal · doi:10.1042/bj2960867 · Cited by 62
Auderset, L., Pitman, K. A., Cullen, C. L., Pepper, R. E., Taylor, B. V., Foa, L., & Young, K. M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.564351 · Cited by 30
Yamamoto, M., Ikeda, K., Ohshima, K., Tsugu, H., Kimura, H., & Tomonaga, M. (1998) · Brain Tumor Pathology · doi:10.1007/bf02482097 · Cited by 25
Metadata
- Authors
- Orth, K., Madison, E. L., Gething, M. J., Sambrook, J. F., & Herz, J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1992-08-15
- Volume
- 89
- Issue
- 16
- Pages
- 7422-7426
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1987207937
- Cited by
- 244
- References
- 2
- FWCI
- 25.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.